Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $41.00K in the quarter ending March 31, 2026, a decrease of -62.39%. This brings the company's revenue in the last twelve months to $525.00K, down -10.71% year-over-year. In the year 2025, Cardiff Oncology had annual revenue of $593.00K, down -13.18%.

• Revenue (ttm): $525.00K
• Revenue Growth: -10.71%
• P/S Ratio: 233.11
• Revenue / Employee: $16,935
• Employees: 31
• Market Cap: 122.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	593.00K	-90.00K	-13.18%
Dec 31, 2024	683.00K	195.00K	39.96%
Dec 31, 2023	488.00K	102.00K	26.42%
Dec 31, 2022	386.00K	27.00K	7.52%
Dec 31, 2021	359.00K	-7.00K	-1.91%
Dec 31, 2020	366.00K	121.37K	49.61%
Dec 31, 2019	244.63K	-133.69K	-35.34%
Dec 31, 2018	378.33K	-127.08K	-25.14%
Dec 31, 2017	505.40K	124.33K	32.63%
Dec 31, 2016	381.07K	68.26K	21.82%
Dec 31, 2015	312.81K	32.63K	11.65%
Dec 31, 2014	280.18K	20.93K	8.07%
Dec 31, 2013	259.25K	-191.16K	-42.44%
Dec 31, 2012	450.40K	192.71K	74.78%
Dec 31, 2011	257.70K	-273.63K	-51.50%
Dec 31, 2010	531.33K	-	-

Data Source: Fiscal.ai Last updated: May 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error